Condition 101 About Rhizomelic Pseudopolyarthritis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Rhizomelic Pseudopolyarthritis

Latest Advances On Rhizomelic Pseudopolyarthritis

  • Condition: Giant Cell Arteritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Tocilizumab
  • Number of Patients: 60
  • Published —
In this study, researchers evaluated the safety and effectiveness of tocilizumab for the treatment of giant cell arteritis.
  • Condition: Polymyalgic complaint
  • Journal: Deutsche medizinische Wochenschrift (1946)
  • Treatment Used: Complete Tumor Resection
  • Number of Patients: 1
  • Published —
This case report describes a 61-year-old caucasian male diagnosed with polymyalgia rheumatica treated with 20?mg prednisone/day, after which MRI revealed a retroperitoneal liposarcoma that was treated with complete tumor resection.

Clinical Trials For Rhizomelic Pseudopolyarthritis

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 20
  • Start Date: January 2021
Beyond Analysis Of Blood Sample, to Approach Immunopathology of Polymyalgia Rheumatica on Shoulder Bursae's Biopsies: the BAOBAB Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 34
  • Start Date: December 1, 2020
BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica (BACHELOR Study)